EUVIMEDEUVIMED entdecken
VergleichsstudieFallberichtOpen Access · CC BY 4.0

Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration

Michael Thy iD, Alexandre Debs, Gabrielle Lui, Leo Froelicher-Bournaud, Jean-Marc Tréluyer, Mehdi Oualha

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70139 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Michael Thy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Intensive et Réanimation Infectieuse, Hôpital Bichat Claude-Bernard, AP-HP, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Ceftazidime, Azabicyclo Compounds, Anti-Bacterial Agents, Continuous Renal Replacement Therapy. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baxter International Foundation, Société de Réanimation de Langue Française.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceftazidime–avibactam is a novel cephalosporin/beta‐lactamase inhibitor combination developed to address increasing antimicrobial resistance. This report presents a comparative study of the pharmacokinetics of ceftazidime and avibactam, utilizing in vitro data derived from two experiments with continuous venovenous hemodiafiltration (CVVHDF) simulation and a comparison with a previously published in vivo case report. The results highlight the importance of therapeutic drug monitoring and the need for higher dosing or continuous infusion of ceftazidime–avibactam in critically ill children under crontinuous renal replacement therapy (CRRT).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeAzabicyclo CompoundsAnti-Bacterial AgentsContinuous Renal Replacement Therapybeta-Lactamase InhibitorsHumansCritical IllnessDrug CombinationsMaleChildChild, PreschoolFemaleHemodiafiltrationDrug Monitoring

Substanzen

Ceftazidimeavibactam, ceftazidime drug combinationAzabicyclo CompoundsDrug CombinationsAnti-Bacterial Agentsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Service de Médecine Intensive et Réanimation Infectieuse, Hôpital Bichat Claude-Bernard, AP-HP, Université Paris Cité, Paris, France.
  • UMR 1343, Evaluation Des thérapeutiques et Pharmacologie périnatale et pédiatrique, INSERM, Université Paris Cité, Paris, France.
  • UMR 1137, IAME, INSERM, Université Paris Cité, Paris, France.
  • Service de Réanimation et Surveillance Continue médicochirurgicales, Hôpital Necker Enfants-Malades, AP-HP, Université Paris Cité, Paris, France.
  • Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France.
  • Unité de Recherche Clinique-Centre D'investigation Clinique, CIC1419, Hôpital Cochin-Necker, AP-HP, Université Paris Cité, Paris, France.

ORCID-Profile: Michael Thy

Förderung

  • Baxter International Foundation
  • Société de Réanimation de Langue Française

Zitieren

APA

Thy, M., Debs, A., Lui, G., Froelicher-Bournaud, L., Tréluyer, J. M., & Oualha, M. (2025). Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70139

Vancouver

Thy M, Debs A, Lui G, Froelicher-Bournaud L, Tréluyer JM, Oualha M. Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70139

BibTeX
@article{Thy2025,
  author = {Thy, Michael and Debs, Alexandre and Lui, Gabrielle and Froelicher-Bournaud, Leo and Tréluyer, Jean-Marc and Oualha, Mehdi},
  title = {Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70139}
}
Kostenlos starten →